Epidemiological and clinical features of hepatitis B virus related liver failure in China

World Journal of Gastroenterology

Volumn 17, Issue 25, 2011, Pages 3054-3059

  Liu, Chen ^a   Wang, Yu Ming ^a   Fan, Ke ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chronic hepatitis B; Epidemiology; Hepatitis B virus related liver failure; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; PROTHROMBIN;

ABDOMINAL DISTENSION; ADULT; AGED; ALCOHOL CONSUMPTION; ANOREXIA; ARTICLE; ASCITES; CHINA; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; ETHNIC GROUP; FAMILY HISTORY; FEMALE; HEPATITIS B VIRUS; HEPATORENAL SYNDROME; HUMAN; LIVER FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY;

EID: 79960241288     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i25.3054     Document Type: Article

References (30)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107
2. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003; 39 Suppl 1: S64-S69
3. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373: 582-592
4. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, Lau GK, Liu Q, Madan K, Mohamed R, Ning Q, Rahman S, Rastogi A, Riordan SM, Sakhuja P, Samuel D, Shah S, Sharma BC, Sharma P, Takikawa Y, Thapa BR, Wai CT, Yuen MF. Acuteon- chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3: 269-282
5. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GK, Locarnini S. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008; 2: 263-283
6. Lai N, Guo SH, Zhang DZ, Shi L, Zhong XN, Yuan CL. A single factor analysis of the prognosis of 301 hepatitis failure cases and a study of a scoring system on their prognostic assessment. Zhongguo Ganzangbing Zazhi 2005; 13: 586-589
7. Ding HG, Gao GJ, Tao C, Rui J. Prognosis of severe types of virus hepatitis: study on multiple risk factors. Linchuang Gandanbing Zazhi 2002; 18: 297-299
8. Acharya SK, Dasarathy S, Irshad M. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality. J Hepatol 1995; 23: 8-13
9. Yuen MF, Sablon E, Hui CK, Li TM, Yuan HJ, Wong DK, Doutreloigne J, Bogaerts V, Wong BC, Fan ST, Lai CL. Prognostic factors in severe exacerbation of chronic hepatitis B. Clin Infect Dis 2003; 36: 979-984
10. Schiødt FV, Ostapowicz G, Murray N, Satyanarana R, Zaman A, Munoz S, Lee WM. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl 2006; 12: 1776-1781
11. Tank PD, Nadanwar YS, Mayadeo NM. Outcome of pregnancy with severe liver disease. Int J Gynaecol Obstet 2002; 76: 27-31
12. Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R. Severe sepsis in cirrhosis. Hepatology 2009; 50: 2022-2033
13. Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghöner A, Vidacek D, Siewert E, Bach J, Geier A, Purucker EA, Gressner AM, Matern S, Lammert F. Patients with acute on chronic liver failure display sepsis-like immune paralysis. J Hepatol 2005; 42: 195-201
14. Galbois A, Thabut D, Tazi KA, Rudler M, Mohammadi MS, Bonnefont-Rousselot D, Bennani H, Bezeaud A, Tellier Z, Guichard C, Coant N, Ogier-Denis E, Moreau R, Lebrec D. Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis. Hepatology 2009; 49: 175-184
15. Tazi KA, Bièche I, Paradis V, Guichard C, Laurendeau I, Dargère D, Legrand A, Fay M, Pedruzzi E, Robin MA, Cazals-Hatem D, Tellier Z, Bernuau D, Feldmann G, Vidaud M, Lebrec D, Ogier-Denis E, Moreau R. In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats. J Hepatol 2007; 46: 1075-1088
16. Regueira T, Bruhn A, Hasbun P, Aguirre M, Romero C, Llanos O, Castro R, Bugedo G, Hernandez G. Intra-abdominal hypertension: incidence and association with organ dysfunction during early septic shock. J Crit Care 2008; 23: 461-467
17. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34: 17-60
18. Riordan SM, Williams R. Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol 2000; 32: 63-76
19. Diagnostic and treatment guidelines for liver failure. Zhonghua Ganzangbing Zazhi 2006; 14: 643-646
20. Wang YM. New concept in nomenclature, classification and diagnosis of liver failure. Chin J Hepatol 2010; 18: 803-804.
21. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41: 1179-1197
22. Diehl AM. Acute and chronic liver failure and hepatic encephalopathy. In: Goldman L, Bennett JC, editors. Cecil textbook of medicine. Philadelphia: Saunders, 2000: 813-816
23. Sen S, Williams R, Jalan R. The pathophysiological basis of acute-on-chronic liver failure. Liver 2002; 22 Suppl 2: 5-13
24. Gu CH, Wang YM. National diagnostic criteria of severe hepatitis and research review. In: Gu CH, Wang YM, editors. Liver failure, Beijing: People's Medical Publishing House, 2002: 9-11
25. Bernuau J. Acute liver failure: avoidance of deleterious cofactors and early specific medical therapy for the liver are better than late intensive care for the brain. J Hepatol 2004; 41: 152-155
26. Häussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008; 57: 1156-1165
27. Merli M, Riggio O. Dietary and nutritional indications in hepatic encephalopathy. Metab Brain Dis 2009; 24: 211-221
28. Freeman RB. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card. Hepatology 2008; 47: 1052-1057
29. Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, Blei AT, Fontana RJ, McGuire BM, Rossaro L, Smith AD, Lee WM. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007; 35: 2498-508
30. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45: 797-805